Millennium Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Millennium Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-67,375	Closed	-$2.68M	–	4024
2016 Q3	$2.68M	Sell	67,375 -45,954	-41%	-$513K	﹤0.01%	1748
2016 Q2	$1.42M	Buy	113,329 +67,861	+149%	+$632K	﹤0.01%	1969
2016 Q1	$372K	Sell	45,468 -64,487	-59%	-$486K	﹤0.01%	2665
2015 Q4	$1.1M	Buy	109,955 +70,124	+176%	+$728K	﹤0.01%	2255
2015 Q3	$385K	Buy	39,831 +4,740	+14%	+$66.5K	﹤0.01%	2792
2015 Q2	$605K	Buy	+35,091	New	+$513K	﹤0.01%	2533
2014 Q3	–	Sell	-3,718	Closed	-$227K	–	4226
2014 Q2	$227K	Buy	+3,718	New	+$226K	﹤0.01%	3050

Millennium Management's TBRA Position: Q4 2016 in Review

Millennium Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 67,375 shares — an estimated $2.68M sold.

Millennium Management first reported a position in TBRA in Q2 2014 and held it in 7 quarters. The position peaked at $2.68M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Millennium Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Millennium Management sold 67,375 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.68M.
Millennium Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 7 quarters.
Millennium Management's Tobira Therapeutics, Inc. Common Stock position peaked at $2.68M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.